FDA APROVAL

٢٤ نوفمبر ٢٠٢٤

HUMA had a significant decline with DELAY in approval over something minor, still waiting see if it holds the 100MA and gets approval. ANALSYTS PREDICT 11$
Some insider selling and possible dilution. Watching 👀

٤ ديسمبر ٢٠٢٤

تم فتح الصفقة

Still holding W 100MA. Director buys 4600 shares today at $4.38. Possible further delays in the future
OR approval for strong gap up whispers are word this week either way.